Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST) "ATTEST"


Phase 2 Results N/A

Summary of Purpose

A pilot evaluation of tenecteplase compared to alteplase in acute ischaemic stroke patients currently eligible for intravenous alteplase treatment in a prospective, randomised, blinded outcome evaluation clinical trial using brain imaging as a biomarker.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 August 2012.

1 Dec 2011 14 Nov 2011 1 Sep 2013 1 Jan 2014 1 Aug 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • Keith Muir